Abstract:
114
formation. The authors proposed that constitutive phosphorylation of S149 prevents G3BP1 115 dimerization and consequently inhibits SG formation; its stress-induced de-phosphorylation 116 would then allow dimerization and promote SG formation. Evidence to support this model was 117 obtained by using overexpressed non-phosphorylatable G3BP1 mutant S149A and 118 phosphomimetic mutant S149E, which showed that S149A G3BP1 efficiently nucleated SGs 119 while S149E failed to do so (Tourriere et al., 2003) . A subsequent study from our lab using stably 120 expressed S149A and S149E G3BP1 mutants in G3BP1/2 double knockout U2OS cells 121 indicated that the S149E mutant is impaired in SG assembly (Kedersha et al., 2016) .
123
Here we report that there are additional mutations in the original pEGFP-C1-G3BP1-S149A and 124 S149E constructs (Tourriere et al., 2003 ) that were generously shared and widely disseminated.
125
These constructs were used in our study (Kedersha et al., 2016) and many other studies (Barr et 
128
NTF2-like domains of the original constructs. Specifically, we identified an alanine to threonine conversion at position 54 in the S149A (actually A54T/S149A) construct, and a serine to proline 130 conversion at position 99 in the S149E construct (actually S99P/S149E). Whereas the single A54T 131 mutation has no effect on SG assembly, the single S99P mutation destabilizes the protein,
132
dominantly inhibits SG formation, and only partly rescues SG formation in G3BP1/2 KO cells.
133
Transient transfections and immunoprecipitations reveal that G3BP1-S99P does interact with 134 USP10 and Caprin1, but exhibits impaired dimerization. It is less efficiently expressed owing its 135 ubiquitination and instability, and co-aggregates with the autophagy adaptor protein 136 sequestosome 1 in vivo. Mapping of the S99P mutations to available crystal structures supports 137 the observed impairment of dimerization. Mass spectrometry (MS) analysis of S149 138 phosphorylation in untreated versus SA treated cells reveals no significant differences, indicating 139 that S149 phosphorylation does not correlate with SG formation. Finally, repaired S149A and 140 S149E constructs lacking these additional mutations behave indistinguishably from wt G3BP1 in 141 their ability to mediate SG assembly.
143
These data show that the impaired ability of the original pEGFP-C1-G3BP1-S149E construct to 144 nucleate or rescue SGs is caused by the accidental S99P mutation, rather than the intentional 145 S149E mutation. This finding impacts other reports that used these plasmids to investigate the 146 functional effects of S149 phosphorylation of G3BP1.
148
Results:
149
G3BP1-S149E contains a second S99P mutation localized within NTF2-like domain of G3BP1
150
We set out to examine how S149 in the acidic region could regulate presumed NTF2-like 151 domain dimer formation, using a 1-168 fragment of G3BP1 previously described (Kedersha et al., 152 2016). After re-cloning G3BP1-168-wt, G3BP1-168-S149A and G3BP1-168-S149E into bacterial 153 expression vectors, we encountered unexpected issues when purifying His-tagged G3BP1-168-154 S149E (Fig. S1A) . While both wild-type and the S149A mutant migrated as soluble proteins with 155 defined peaks in size exclusion chromatography (SEC), the S149E protein appeared as a major 156 peak in the void volume, but not at the expected molecular weight (Fig. S1A) . Therefore, we 157 checked the sequences of the bacterial expression plasmids and discovered secondary 158 mutations of Ala-54 to Thr (A54T) and to Pro (S99P) in the G3BP1-S149A and G3BP1-159 S149E mutants, respectively. We then identified these same mutations in the original stocks of 160 pEGFP-C1-G3BP1-S149A and S149E (Tourriere et 
164
Structural analysis of the crystal structure reveals that Ala-54 is localized in a loop region 165 preceding the III helix, in hydrophobic contact with Tyr-56 and Val-41. While its substitution to
166
Thr most probably has only minor effects, its close proximity to His-83 of the neighboring chain 167 could affect G3BP1 dimerization (Fig. 1C) , possibly explaining the observed altered mobility of 168 the A54T/S149E mutation relative to wt G3BP1 in size exclusion chromatography (Fig. S1A) . In 169 contrast, Ser-99 is localized at the end of strand III, embedded in a -sheet-mediated hydrogen 170 bond pattern with His-74 of strand II, and its side chain hydroxyl-group is fixed by another 171 hydrogen bond to the carbonyl backbone of Gln-103. Substitution of Ser-99 to Proline has major 172 consequences, as it disrupts the hydrogen-bond pattern, and also rigidifies the peptide 173 backbone (Fig. 1C ). An in silico substitution of Ser-99 to proline renders the formerly favored Phi
174
and Psi angles of the Ser-99 backbone (Fig. S1B, panel 1 , green arrows) into disallowed regions 175 of the proline backbone in Ramachandran plots (Fig. S1B, panel 4 , red arrows). In addition, we 176 used the RosettaBackrub server to predict residues that are tolerated at these positions, and to 
183
compared to the wild-type structure (Fig. S1D) . Thus, we conclude that the S99P mutation was 184 the main cause of our failed protein purification attempt for the presumed S149E variant. We 185 then hypothesized that the same S99P mutation may account for in vivo phenotypes ascribed to 186 S149E, as the "S149E" construct was really the double mutant S99P/S149E. To test this 187 hypothesis, we ascertained the effects of each single mutation on SG formation, and also 188 revisited the phosphorylation state of G3BP-S149 during stress using mass spectrometry (MS).
190
S99P disrupts SG condensation while S149E does not
191
We transfected U2OS-wt cells with the indicated constructs and assessed SG formation
192
with/without sodium arsenite (SA) treatment (Fig. 1D, 1E ). We counterstained the transfected 193 cells for SG markers TIA1 and eIF4G1, to confirm bona fide SG formation (Fig. 1E) . Cells
194
transfected with GFP-tagged G3BP1-wt, A54T, S149A, S149E, and A54T-S149A displayed 195 comparable rates of SG formation, but cells transfected with S99P and S99P-S149E exhibited
196
fewer SGs than the other forms of G3BP1 and fewer than the GFP only control (Fig. 1D, 1E ),
197
consistent with the results obtained in COS7 cells reported earlier (Tourriere et al., 2003) . In 198 cells treated with SA, all GFP-G3BP1 variants are recruited to SGs. G3BP1 variants containing the 199 S99P mutation significantly repress both spontaneous and SA-induced SGs (Fig. 1D, E) , in partial 200 agreement with the original study, which showed that G3BP1-(S99P)-S149E inhibited 201 spontaneous but not SA-induced SGs.
202
We next assessed the extent to which the various forms of G3BP1 can rescue SGs in 203 G3BP1/2 U2OS cells, which lack endogenous G3BP1 and G3BP2 proteins and are unable to
204
form SGs in response to most stresses. SG competence is rescued by reconstituting these cells 205 with exogenously-expressed G3BP1, either transiently or stably (Kedersha et al., 2016) .
206
Transient transfection of G3BP1/2 U2OS cells reveals that G3BP1-wt, A54T, S149E and A54T-207 S149A all rescue the formation of SGs to comparable levels ( Fig. 2A and B) . A very modest 208 increase in SG nucleation without stress was observed upon transfection with the S149A mutant 209 (Fig. 2B, * columns) . However, variants bearing the S99P mutation were significantly impaired in 210 their ability to nucleate (without stress) or rescue (with stress) SG formation ( Fig. 2A, quantified 
211
in 2B, ** columns). In addition to SA, other stresses (clotrimazole and pateamine A) gave similar results (Fig. S2) . Constructs bearing the S99P mutation were significantly less effective at
213
rescuing SGs under all stress conditions (Fig. 2B , ** columns).
215
Increased proteolysis of G3BP1-S99P impairs SG formation
216
The reduced ability of S99P constructs to rescue SGs could be due to lower expression 217 levels. To assess this, we transiently transfected G3BP1 constructs into G3BP1/2 U2OS and 218 quantified the protein levels using western blotting. Consistently, the constructs harboring the 219 S99P mutation showed reduced protein expression relative to G3BP1-wt and the other mutants 220 (Fig. 2C, 2D) . A longer exposure revealed that the S99P containing constructs were missing a 49 221 kDa band and displayed different lower molecular weight species (Fig. 2C, 2D ). This is consistent 222 with earlier data (Kedersha et al., 2016) , which showed lowered expression/altered breakdown 223 products with the original S149E mutant and a shorter piece containing the NTF2-like domain,
224
both of which we now realize contained the additional S99P mutation.
225
We previously noticed that the S99P/S149E construct expressed poorly relative to the 226 other G3BP1 variants in COS7 cells, the same cells used in the original study (Tourriere et al., 
227
2003). To validate our U2OS findings (Fig. 1D, 1E and 2A, 2B), we then transfected COS7 cells
228
with GFP-tagged versions of wt, S149E, S99P, and the original double mutant S99P/S149E G3BP1 229 (Fig. 3) , and stained for the SG marker eIF3b (blue) and for sequestosome-1 (Fig. 3A-D 
232
G3BP1-wt or S149E are positive for eIF3b and do not contain sequestosome-1 (Fig. 3A, 3B ), as 233 expected. However, SGs nucleated by G3BP1-S99P or S99P/S149E display eIF3b-positive SGs 234 containing subregions positive for sequestosome-1 (Fig. 3C, 3D , red arrows). To determine 235 whether the S99P constructs were less efficiently translated, we co-transfected a neutral 236 reporter and quantified proteins via western blotting. G3BP1 levels were normalized to reporter,
237
and the mutants plotted relative to the normalized G3BP1-wt. The expression of the S99P 238 variant was significantly reduced relative to WT (Fig. 3E, Fig. S3A ). A short (6h) treatment with 239 the proteasome inhibitor MG132 modestly increased its expression, but this was not significant 240 (Fig. S3A) . GFP-immunoprecipitation confirmed elevated ubiquitination in the S99P constructs 241 (Fig. 3F) . Taken together, the data indicate that S99P is unstable, ubiquinylated, and degraded
242
(possibly in part through sequestosome-targeted autophagy), but GFP-G3BP1-S99P expression
243
does not reduce global translation levels or transfection efficiency, as shown by the co-transfected reporter. Reduced expression may in part explain the reduced ability of G3BP1-S99P 245 to rescue SGs ( Fig. 2A, 2B ) in cells lacking endogenous G3BP, but it does not explain its apparent 246 dominant-negative effects on SGs in cells that express endogenous G3BP (Fig. 1D) .
247
Another property ascribed to the G3BP1-S149E phosphomimetic is increased 248 interaction with co-expressed FLAG-Disheveled-2 (Sahoo et al., 2012); this study used the 249 original S149E plasmid. To replicate these findings and ascertain whether they were due to the 250 S149E or to the S99P mutation, we co-transfected our single-mutant constructs with Flag-tagged
251
Disheveled-2 in COS7 cells, and assessed colocalization of the proteins (Fig. S3B) . The results
252
show that DVL2 only associates with G3BP1-S99P, not with G3BP1-wt or G3BP1-S149E (Fig. S3B ).
253
Remarkably, both our data and that in (Sahoo et al., 2012) show that the DVL2:G3BP1 254 localization is not perfectly coincident, but shows that DVL2 forms a shell around G3BP1-S99P,
255
segregating it from the SG marker eIF3 (Fig. S3B ). While the significance of this is not clear, the 256 data suggest that the S99P mutation likely was responsible for the effects attributed to S149E.
257
What does the serendipitous S99P mutation tell us about G3BP-mediated SG 
279
Thus far, all data suggest that the S99P mutations account for the phenotype 280 attributed to S149E, but the phosphorylation status of S149 during SG formation remains 281 unclear. We first addressed this issue using a commercial phospho-specific antibody to the S149 282 site from Sigma (G8046), but found that the antibody reacted with non-phospho GFP-G3BP-283 S149A in G3BP1 KO cells (Fig. S3C) . We then employed an IP/MS approach, in which we IP'd 284 endogenous G3BP1 from untreated or arsenite-treated U2OS cells, then used MS to assess the 285 phosphorylation status of two reported sites, G3BP1-S149 and G3BP1-S232 (Fig. 4A, n=4 ). We 286 also examined the phosphorylation of GFP-G3BP1 stably expressed in G3BP1/2 U2OS cells 287 and precipitated using anti-GFP (Fig. 4B, n=6 ). In contrast to the original data which was 
289
we do not see a SA-induced decrease in phosphorylation at S149 in U2OS cells. On the contrary,
290
we observe a modest but a statistically insignificant increase in S149 phosphorylation. We note 
295
relative to other peptides analyzed by MS. To recover this peptide, we used large amounts of 296 starting material. We attempted to assess the phosphorylation of the homologous serine in 297 G3BP2, but failed to recover any S149 peptides, as this protein contains an even higher density 298 of acidic residues, presumably the cause of the unreliably low recovery of the phosphopeptide 299 by liquid chormatography/MS. We also assessed the phosphorylation of another site (S232) 300 previously reported to be unaffected by stress (Tourriere et al., 2003) , and confirm that we see 
306
G3BP is essential for SG assembly; cells lacking both G3BP1 and G3BP2 cannot assemble SGs 307 when challenged with all known p-eIF2 dependent and some p-eIF2 independent stresses 308 (Kedersha et al., 2016) . The ability of G3BP1 to form SGs was reported to be regulated by the 309 phosphorylation state of serine 149, such that de-phosphorylation of this amino acid promotes 310 SG formation (Tourriere et al., 2003) . In an attempt to study this posttranslational modification 311 in more detail, we discovered additional mutations in the original constructs that were 312 generously shared and widely distributed within the field. Specifically, we found that the pEGFP-313 C1-G3BP1-S149A (non-phosphorylatable) construct contains an additional alanine to threonine 314 conversion at position 54, while the pEGFP-C1-G3BP1-S149E (phosphomimetic) construct 315 contains an additional serine to proline mutation at position 99 (Fig. 1A) . While we had originally 316 sequenced the plasmids in 2004 to confirm the existence of the expected mutations at the S149 317 site, we did not sequence the entire coding region.
319
We created repaired constructs to contain only single mutations, then assessed their ability to 320 nucleate SGs upon transient overexpression in U2OS cells, and for their ability to rescue SGs in 321 G3BP1/2 U2OS KO cells. Our data (Fig. 1, 2 and S2) show that constructs containing only 322 S149A or S149E displayed no statistical difference in their ability to nucleate or rescue SGs, in 323 contrast to published data (Kedersha et al., 2016; Tourriere et al., 2003) . Moreover, we were 324 unable to detect any significant SA-induced changes in the phosphorylation status of the S149 325 site in endogenous immunoprecipitated G3BP1 (Fig. 4A) , or in GFP-G3BP1 stably expressed in 326 G3BP1/2 U2OS (Fig. 4B) . Our data show that the S99P mutation is the sole cause of the 327 previously described phenotype of impaired SG formation and SG rescue, and do not support 328 the idea that phosphorylation of S149 promotes SG formation.
330
We mapped the exact positions of the unintentional mutations A54T and S99P in the publically 
332
The S99P change disrupts three hydrogen bonds within the -sheet and a sheet-associated loop 333 region (Fig. 1C) , but also rigidifies the peptide backbone due to the structure of proline (Fig.   334 S1B). These changes destabilize the protein to an extent that let us fail to purify the bacterially-335 expressed mutant protein (Fig. S1A ), but more importantly render G3BP1 more sensitive to 336 degradation when expressed in cells (Fig. 2C, 2D, Fig. 3 ). This is supported by in vivo data showing that G3BP1-S99P is less efficiently expressed (Fig. 2C, 2D , 3G, 3I), ubiquitinylated (Fig. 
338
3F), and differently processed (Fig. 2C, 2D ) relative to G3BP1-wt.
340
While S99P destabilizes G3BP1, it does not prevent interactions with USP10 or Caprin1 (Fig. 3G, 
341
3H), which bind the NTF2-like domain and regulate SG formation in vivo. However, S99P 342 mutations reduce dimer formation as shown by the reduced interaction of G3BP1-S99P with 343 G3BP-wt, and the drastically reduced interaction of G3BP1-S99P with itself (Fig. 3I, 3J, 3K ). As 344 dimerization of G3BP is likely required for SG assembly, the failure of S99P mutants to interact , are not reproduced in our system. In six biological replicates, we detected no 357 significant difference in S149 or S232 phosphorylation in response to SA treatment (Fig. 4A, 4B ).
358
Moreover, MS analysis of phophorylation of S149 and S232 of endogenous G3BP1 (Fig. 4A) , and
359
GFP-tagged stably expressed G3BP1 (Fig 4B) , showed a modest but not significant increase upon
360
SA treatment, suggesting that S149 phosphorylation does not influence G3BP's ability to 
366
Our findings may impact the interpretation of other studies which utilized the original pEGFP-
367
C1-G3BP1-S149A and S149E constructs. The deacetylase HDAC6 interacts with G3BP in vivo and 368 in vitro. Reduced binding of the S149E mutant suggested that phosphorylation modulates the HDAC6:G3BP interaction (Kwon et al., 2007) , which was mapped to G3BP1 fragments containing 370 the S149 site (the acidic region) but lacking the NTF2-like domain, hence it is possible that S149 371 regulates interactions with HDAC6 but not SG formation. It is notable, however, that HDAC6 has 372 not been identified as a SG component in two major studies using proximity labeling to catalog 373 SG components (Markmiller et al., 2018; Youn et al., 2018) . Another study reported that S149E 374 specifically interacts with Dvl2, a cytoplasmic Wnt signaling effector, but not with the non-375 phosphorylatable mutant S149A (Sahoo et al., 2012) . Using G3BP1 fragments and co-IPs, the 376 G3BP1:Dvl2 interaction was mapped to the NTF2-like domain and colocalization data was shown 377 using immunofluorescence. To explain their results, the authors proposed that S149 378 phosphorylation changes the conformation of G3BP1 NTF2-like domain, promoting its 379 interaction with Dvl2. While this is possible, the conformational change may be due to the S99P 380 mutation rather than the S149E mutation, as we show that the S99P mutation mediates DVL2 381 colocalization in foci that lack the SG marker eIF4G1 (Fig. S3B) . 
399
This study also shows that SIRT6 influences the phosphorylation of G3BP1 at serine 149, but no 400 differences were reported on the interaction between SIRT6 and G3BP1-S149A or S149E 
407
and S149E plasmids, the authors showed that S149E did not aggregate HuR-positive SGs, and 408 S149E showed a higher mobility in FRAP recovery experiments. S149 phosphorylation in 409 regenerating neurons was shown using commercial phosphospecific antibody. The authors
410
report that S149 is de-phosphorylated upon SA treatment, again by using the S149 411 phosphospecific antibody, but unfortunately the data is not shown.
413
Rasputin, the single Drosophila ortholog of G3BP1/G3BP2, does not require phosphorylation at 414 S142 (orthologous to mammalian S149) for SA-induced SG assembly, but phospho-S142 is 
421
It is clear that phosphorylation of endogenous G3BP occurs at S149, but the meaning of this is 422 still unresolved. Our data indicate that S149 phosphorylation is not a simple switch that 423 determines whether G3BP assembles SGs. It is still possible that S149 phosphorylation 
434
The original constructs encoding pEGFP-C1-G3BP1-wt, pEGFP-C1-G3BP1-S149A and pEGFP-C1-
435
G3BP1-S149E were a kind gift from Jamal Tazi, and were obtained from his lab on two 436 independent occasions (July 2004, and July 2016), and sequenced throughout the coding region.
437
Mutations were introduced into pEGFP-C1-G3BP1-wt as follows. The 5' phosphorylated primers
438
(see Table S1 for sequences) were mixed with 1 ng of pEGFP-C1-G3BP1-wt plasmids in a 1x
439
Phusion PCR mastermix (Thermo Fisher Scientific) at a final volume of 25 L. The mixture was 440 denatured at 98°C for 30s, followed by 25 cycles of the following: 98°C for 10s, 60°C for 15s,
441
72°C for 2 min 30s, with a final extension step of 72°C for 5 min. 25 ng of the PCR product was 5´Phos-CCAGCAGATGCAGTCTACGGACAGAAAG 5´Phos-CTTTCCATTTGAATCCAATCCCCCATGGA S149E pEGFP-G3BP-S99P-S149E 5´Phos-GGGGCTTCTCTCTAACAACAACCAGG 5´Phos-ATCACCTGGACTACCACACCATCATTTAGC Table S1 : Primer sequences.
450
Bacterially-expressed protein production:
451
The pET28-G3BP1-168-wt, S149A-(A54T) and S149E-(S99P) expression vectors were transformed 452 into T7 express cells (NEB) and proteins were produced as described previously (Schulte et al.,
453
2016). The poly-histidine-tagged G3BP-1-WT as well as the mutated S149A and S149E constructs
454
were purified using immobilized metal affinity (IMAC, HisTrap FF, GE Healthcare) and the dimer 455 was isolated using size exclusion chromatography on a Superdex 75 column (GE Healthcare).
457
Structural analysis:
458
The structure and the effect of the mutations were analyzed using PyMOL, Arpeggio, PHENIX proteins. Cells were scored for SGs by manual counting using fluorescent microscopy, using TIA1
478
and eIF4G1 or eIF3b as SG markers; only cells with granules co-staining for these markers were
479
considered SGs, and a minimum of 3 granules per cell was required to score as positive.
481
Immunoblotting:
482
Transient transfected COS7, G3BP1/2 U2OS cells were lysed in EE-lysis buffer (50 mM HEPES, 
498
and blotted using standard procedures. Chemiluminescent was detected using SuperSignal West
499
Pico substrate (Thermo Fisher Scientific). COS7 cells were transfected and immunoprecipitated 500 using GFP-TRAP (ChromoTek), as described previously (Kedersha et al., 2016) .
502
Immunoprecipitation of GFP-G3BP1-wt for mass spectrometry: 
505
PBS, and scrape-harvested at 4°C into EE-lysis buffer. Cells were rotated for 10 min at 4°C,
506
cleared by centrifugation (10,000 g, 10 min, 4°C), and incubated with anti-GFP beads for 2h with 507 continuous rotation at 4°C. Beads were washed two times in EE-lysis buffer (500 mM NaCl) and 508 three times in standard EE-lysis buffer (150 mM NaCl), then eluted directly into 2x SDS-sample 509 buffer. Proteins were resolved in a 4-12% NuPAGE BT gel (Invitrogen) and stained with
510
Coomassie Blue. GFP-G3BP1-wt bands were excised and sent for mass spectrometry. In a second 511 experimental setup we generated G3BP1 peptides by on bead trypsin digest, skipping SDS-PAGE
512
and Coomassie Blue staining.
514
Immunoprecipitation of endogenous G3BP1 for mass spectrometry 515 150 mm dishes of 80-90% confluent U2OS-wt cells were treated and lysed as described above.
516
The day before harvest respectively 150 g of protein G beads (Pierce, Thermo Fisher Scientific) 
568
Precursors were isolated with a 2 m/z window and a 0.5 m/z offset. Automatic gain control
569
(AGC) targets were 1e6 for MS1 and 1e5 for MS2. Maximum injection times were 100 ms for
570
MS1 and 400 ms for MS2. The entire duty cycle lasted ~1.5 s. 
589
Immunofluorescence:
590
Cells were fixed and processed for fluorescence microscopy as described previously (Kedersha
591
and Anderson, 2007) . Briefly, cells were grown on glass coverslips, stressed as indicated, fixed 592 using 4% paraformaldehyde in PBS for 10 min, followed by 5 min post-fixation/permeabilization 593 in ice-cold methanol. Cells were blocked for 1h in 5% horse serum/PBS, and primary and 594 secondary incubations performed in blocking buffer for 1h with rocking. All secondary
595
antibodies were multi-labeling grade (tagged with Cy2, Cy3, Cy5, Jackson Immunoresearch).
596
Following washes with PBS, cells were mounted in polyvinyl mounting media and viewed using a
597
Nikon Eclipse E800 microscope with a 63X Plan Apo objective lens (NA 1. 
669
Transient co-expression of GFP-G3BP1 mutants with an HA-tagged reporter construct,
670
quantified by western blot/densitometry for GFP and HA (Fig. S3A) , expression of GFP to HA was 671 normalized relative to the wt control, and relative values were plotted. Data shown are mean
672
+/-SEM and analyzed using unpaired t-test. ns, not significant; **, P < 0.01; ***, P < 0.001 ; n = 
689
analysis of endogenous G3BP1-S149 and G3BP1-S232 phosphorylation following mock or 1h SA
